CONMED Corporation

CNMD Healthcare Medical Devices

CONMED Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 5.18% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 11.6%, free cash flow grew 46.0% and total debt fell 5.40%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.

46.72 0.42 −0.89%
Market cap
$1.4B
P/E
25.3×
Fwd P/E
8.8×
Dividend yield
0.00%
F-score
5/9
Altman Z
1.86
Beneish M
−2.70
Dividend safety
63/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

22.83 26.89 19.98 17.69
P/S ratio
1.08 0.92 0.79 0.72
P/FCF ratio
9.77 8.35 8.74 7.32
P/Operating CF
27.12 27.19 80.28 26.53
P/B ratio
1.44 1.22 1.06 0.95
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
1.69 1.49 1.39 1.30
EV/EBITDA
11.50 11.25 9.91 9.33
EV/Operating CF
13.54 12.03 13.37 11.83
EV/FCF
15.24 13.61 15.42 13.25
Quick Ratio
0.84 0.92 0.90 0.61
Current Ratio
2.10 2.14 2.29 1.48
Net Debt/EBITDA
25.65 13.93 18.14 14.10
Debt/Assets
36.76% 35.90% 37.19% 36.27%
Debt/Equity
0.85 0.81 0.85 0.80
Asset Turnover
0.58 0.59 0.59 0.59
Operating CF/Net income
18.78 2.77 0.97 1.61
Capex/Depreciation
(0.26) (0.25) (0.14) (0.15)
Interest Coverage
1.56 4.97 3.60 4.62
Research and Development Expense of Revenue
4.11% 3.99% 5.15% 4.51%
Selling, General and Administrative Expense of Revenue
41.53% 44.68% 44.69% 42.37%
Intangible Assets out of Total Assets
0.60 0.60 0.60 0.59
Share Based Compensation of Revenue
1.36% 1.33% 1.74% 1.52%
Graham Net Nets
(0.45) (0.49) (0.58) (0.59)
Graham Number
38.86 33.63 36.40 37.97
Earnings Yield
4.38% 3.72% 5.01% 5.65%
Free Cash Flow Yield
10.23% 11.97% 11.44% 13.66%
Revenue per Share
10.92 12.02 10.37 11.42
Operating CF per Share
1.73 1.49 0.44 1.23
Capex per Share
(0.17) (0.16) (0.09) (0.10)
Free Cash Flow per Share
1.57 1.33 0.35 1.14
Cash per Share
1.26 1.32 1.15 1.24
Shareholders Equity per Share
32.57 33.29 33.27 34.63
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
32.57 33.29 33.27 34.63
Free Cash Flow
48.50 41.22 10.58 34.16
Working Capital
347.46 357.82 377.88 220.27
Capital Expenditures
(5.19) (5.11) (2.89) (2.93)
Net Current Asset Value
(652.07) (619.79) (626.68) (583.25)
EV/EBIT
19.16 20.02 17.02 16.14
Capex to Sales
0.02 0.01 0.01 0.01
Price to Operating Income
12.29 12.28 9.65 8.92
Other line items
Average Receivables
228.09 242.78 224.90 236.96
Average Payables
105.83 97.95 100.57 101.04
Average Inventory
353.45 351.13 360.39 361.22
Average Assets
2,319.12 2,316.00 2,306.31 2,314.38
Average Common Equity
970.58 997.89 997.65 1,022.13

Fold the line items

Columns are period end dates